(Date:12/16/2009)... INDIANAPOLIS, Dec. 16 /PRNewswire/ -- ... Indiana,s life sciences industry and an active venture ... Company, Indiana State Teachers Retirement Fund, Indiana University, ... M. Fairbanks Foundation, and Credit Suisse today announced ... million venture capital fund of funds. ,, Organized ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... The American Filtration and Separations Society will hold its 23rd Annual ... Hyatt Hotel in San Antonio, Texas. To further impact the separation ... we are proud to announce that the 2010 AFS Annual Technical ... , , ... Minneapolis, MN (PRWEB) December 16, 2009 ...
(Date:12/15/2009)... HARBIN, China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully integrated ... People,s Republic of China ("PRC"), today,announced that the ... in the 2009,Edition of the National Basic Medical ... , The 30 medicines ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3... Financial Results, VANCOUVER, Jan. 22 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... company, will host a conference call discussing its,financial results for the ... Thursday, February 14, 2008 at 11:00 AM ET ... 10:00 AM Central), Dial information is ...
... Hospitals and healthcare,institutions are challenged to ... to take place while maintaining Environment of ... addresses these challenges is,available for download at: ... titled "Infection Control in the Healthcare,Environment During ...
... BASEL, Switzerland and TUCSON, Ariz., Jan. 22 ... healthcare,provider of pharmaceuticals and diagnostics, and Ventana Medical ... they have signed a,definitive merger agreement. Under the ... price in the tender offer for Ventana common ...
Other Biology Technology:Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast 2White Paper Details Infection Control Challenges Hospitals Must Address During Construction 2Roche to Acquire Ventana for $89.50 per share 2Roche to Acquire Ventana for $89.50 per share 3Roche to Acquire Ventana for $89.50 per share 4Roche to Acquire Ventana for $89.50 per share 5Roche to Acquire Ventana for $89.50 per share 6... ... and interfaces, SACRAMENTO, Calif., May 5 ... Technologies announced,an enhanced version of its Jail Booking and Management System ... accounts and costs., Part of the innovative E*JUSTICE SYSTEMS(TM) public ...
... Spanish . , Over the past decades ... planet have given rise to a growing scientific interest ... that currently dominate our energy map are not only ... contaminating gases. Within the field of renewable energies the ...
... an important role to play in the fate of potentially ... campaigns, according to a new report in the May 6th ... , The researchers found evidence that fungi can lock depleted ... to find its way into plants, animals, or the water ...
Other Biology News:CrimeCog Technologies Unveils Enhanced JMS Module of E*JUSTICE SYSTEMS(TM) 2CrimeCog Technologies Unveils Enhanced JMS Module of E*JUSTICE SYSTEMS(TM) 3More efficient fuel-cells, thanks to a new catalyst 2More efficient fuel-cells, thanks to a new catalyst 3More efficient fuel-cells, thanks to a new catalyst 4Fungi have a hand in depleted uranium's environmental fate 2prototype Nco I...
Request Info...
Agarose for baculovirus plaque assays which allow optimal growth of plated insect cells....
Includes USB cable, custom driver and one roll of thermal paper...
Biology Products:Biology NavigationMedical Navigation